Tartrazine (CI 19140), 100 g, emballage verre

4-(Methylsulfonyl)phenylacetic acid, 97.0%, 1g

2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3,3-dimethylbutanoic acid, 97%, 1g

(S,R,S)-AHPC-PEG2-N3, 500mg

1-Boc-4-hydroxy-2-oxo-2,5-dihydro-pyrrol, 98.0%, 25g

Ampoules pré-percées Verre transparent, 5 ml, 144 pièce(s)

tert-Butyl 4-(3-chlorophenyl)-4-cyanopiperidine-1-carboxylate, 95%, 1g

Ethyl 2-methoxyisonicotinate, 95.0%, 5g

3-cyclopentylpropanoyl chloride, 95.0%, 5g

4-Methylthiophene-2-carbaldehyde, 95.0%, 250mg

(2E)-1-(3,4-dichlorophenyl)-3-(3-methylthiophen-2-yl)prop-2-en-1-one, 95.0%, 2g

2-Methyl-2-(methyl(oxetan-3-yl)amino)propanal, 97%, 500mg

5-(4-Fluoro-phenyl)-furan-2-carboxylic acid, 95.0%, 250mg